Pancreatic cancer is 'always non-resectable'

Digestive Diseases

Volumn 25, Issue 3, 2007, Pages 285-288

  Mönkemüller, Klaus ^a,b   Fry, Lucia C ^a   Malfertheiner, Peter ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Curative resection, feasibility; Pancreatic cancer surgery; Pancreatic cancer, always non resectable; Pancreatic cancer, epidemiology; Specialized referral centers

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER INVASION; CHRONIC PATIENT; CONFERENCE PAPER; DEATH; DELAYED DIAGNOSIS; GERIATRIC PATIENT; HUMAN; OUTCOME ASSESSMENT; PANCREAS CANCER; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SURGICAL STRESS; TREATMENT CONTRAINDICATION; ARTICLE; PANCREAS; PANCREAS TUMOR; PATHOLOGY; TREATMENT OUTCOME;

HUMANS; PANCREAS; PANCREATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 35448968730     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103904     Document Type: Conference Paper

References (23)

1. Li D, Xie K, Wolff R, Abbruzzese JL: Pancreatic cancer. Lancet 2004;363:1049-1057.
2. Böhmig M, Rosewicz S: Pancreatic carcinoma. Z Gastroenterol 2004;42:261-268.
3. Willett CG, Czito BG, Bendell JC, Ryan DP: Locally advanced pancreatic cancer. J Clin Oncol 2005;23:4538-4544.
4. Saif MW: Pancreatic cancer: highlights from the 42nd Annual Meeting of the American Society of Clinical Oncology, 2006. JOP 2006;7:337-348.
5. Eloubeidi MA, Desmond RA, Wilcox CM, Wilson RJ, Manchikalapati P, Fouad MM, Eltoum I, Vickers SM: Prognostic factors for survival in pancreatic cancer: a population-based study. Am J Surg 2006;192:322-329.
6. Brenner H, Stegmaier C, Ziegler H: Long-term survival of cancer patients in Germany achieved by the beginning of the third millennium. Ann Oncol 2005;16:981-986.
7. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE: Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346:1128-1137.
8. Van Heek NT, Kuhlmann KF, Scholten RJ, de Castro SM, Busch OR, van Gulik TM, Obertop H, Gouma DJ: Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands. Ann Surg 2005;242:781-788.
9. Fernandez JA, Parrilla P: What are the main errors made by surgeons in the management of pancreatic cancer? Cir Esp 2006;79:215-223.
10. Postier RG: The challenge of pancreatic cancer. Am J Surg 2003;186:579-582.
11. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Büchler MW: Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 2004;91:586-594.
12. Smeenk HG, Tran TC, Erdmann J, van Eijck CH, Jeekel J: Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist? Langenbecks Arch Surg 2005;390:94-103.
13. Michaud DS: Epidemiology of pancreatic cancer. Minerva Chir 2004;59:99-111.
14. Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP: Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 1995;82:111-115.
15. Seiler CA, Wagner M, Bachmann T, Redaelli CA, Schmied B, Uhl W, Friess H, Büchler MW: Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg 2005;92:547-556.
16. Freeny PC: Pancreatic carcinoma: imaging update 2001. Dig Dis 2001;19:37-46.
17. Ishikawa O, Ohhigashi H, Sasaki Y, Kabuto T, Fukuda I, Furukawa H, Imaoka S, Iwanaga T: Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg 1988;208:215-220.
18. Kayahara M, Nagakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I: An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 1993;72:2118-2123.
19. Gudjonsson B: Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting. J Am Coll Surg 1995;181:483-503.
20. Picozzi VJ, Kozarek RA, Traverso LW: Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 2003;185:476-480.
21. Stojadinovic A, Brooks A, Hoos A, Jaques DP, Conlon KC, Brennan MF: An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma. J Am Coll Surg 2003;196:954-964.
22. Liu SL, Friess H, Kleeff J, Ji ZL, Büchler MW: Surgical approaches for resection of pancreatic cancer: an overview. Hepatobiliary Pancreat Dis Int 2002;1:118-125.
23. Tran KT, Smeenk HG, van Eijck CH, Kazemier G, Hop WC, Greve JW, Terpstra OT, Zijlstra JA, Klinkert P, Jeekel H: Pylorus-preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 2004;240:738-745.